Kratom Formulations and Safety Update


“Kratom Formulations and Safety Update”

Wednesday, April 16th, 2025 | 12:00 – 01:00 PM Eastern | Zoom

Speaker

[empty]

Oliver Grundmann, BPharm, MS, PhD

Department of Medicinal Chemistry

University of Florida College of Pharmacy


Program Details

  • Intended Audience:  Pharmacists
  • Universal Activity Number: 0012-0000-25-016-L01-P
  • Contact Hours: 1.0 hour of ACPE continuing education for pharmacists
  • Program Fees: 
    • Regular Registration: $10.00
    • UF Preceptor/Career Coach: $5.00
    • UF COP Faculty: $0.00 (Free!)
  • UAN Release Date: 04/16/2025
  • UAN Expiration Date: 12/31/2025
  • Activity Type: Knowledge
  • Program Support: No outside financial support was provided.
  • Format Type: Live, webinar (Zoom)
  • Time to Complete: Course completion requirements must be met within 15 days following the conclusion of the webinar.

Summary

The increasing prevalence of kratom products and their use in the US has resulted in a diverse market that reached over $1 billion in the US in 2023. Product diversity has resulted in the sale of kratom leaf material, kratom extracts which contain higher amounts of the active alkaloid mitragynine and other alkaloids, concentrates, and isolated compounds such as 7-hydroxymitragynine and mitragynine pseudoindoxyl. Although several states have regulated kratom products in general, little current regulation addresses the potency of such products and the associated safety risks. This update is aimed at practicing pharmacists to understand the diversity of kratom products, potential drug interactions, and emerging safety concerns.

This course is approved by the Florida Board of Pharmacy for 1.0 live general hours to meet pharmacist renewal requirements outlined in Rule 64B16-26.103.


Objectives

At the completion of this activity, the participant will be able to:

  1. Analyze kratom product labels and publicly available information to determine the composition of a product.
  2. Determine the potential for drug interactions and toxicity based on the known pharmacology of kratom alkaloids.
  3. Create a counseling plan based on kratom product type and the individual needs and medical history of the patient.

Requirements for Successful Course Completion

In order to earn credit for this course, participants must attend the webinar live. Additionally, within 15 days of attending the webinar, participants must complete a course evaluation form.


Course Access

The Zoom link will be provided in your receipt of payment. For additional assistance, please see our contact information below.


Disclosure Statement

Oliver Grundmann, BPharm, MS, PhD (Planning Committee, Faculty) has disclosed that he is performing an expert report on the toxicity of kratom for Kava Co, LLC. All relevant financial relationships for Dr. Grundmann have been mitigated. No other faculty, planners, or others in a position to control content have any financial relationships with ineligible companies to disclose.

Visit https://cpe.pharmacy.ufl.edu/coi-resources/ for more information on management of conflicts of interest.


Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.